The Lancet’s Post

Publish your 𝐎𝐩𝐢𝐧𝐢𝐨𝐧 Piece with my Personal Guide! I have been using this guide for the last 2 years and have successfully published more than 20 opinion pieces in the top journals such as The Lancet, BMC, PLoS, Nature, etc. You can use it as a framework. #opinionpiece #academia #research

Individual and community-level factors associated with caesarean section in Haiti: secondary analysis of data from the 2016–2017 Haitian Demographic and Health Survey | Tropical Medicine and Health | Full Text (biomedcentral.com) #oneofnewpaper

GEROSCIENCE: The field of aging continues to mature. This is an exciting time for geroscience. Research interest is high. Breakthroughs are coming. Visionaries are investing. See new article here by Dr. Mehmood Khan and colleagues, Haya Al Saud, Felipe Sierra, Viviana Perez, William Greene, Salman Alasiry, Sophia Pathai MD, PhD, MSc & Michael Torres. Kudos on the new paper! Global Healthspan Summit 2023: closing the gap between healthspan and lifespan - https://lnkd.in/eF7Cf2bv

In an article published in The Lancet, Orygen's Chief of Research, Professor Eoin Killackey, has proposed a new framework to help foster inclusivity in research. It's called the 4L framework, and adds three new dimensions to the concept of 'lived experience'. Click here to read Eoin's article: https://bit.ly/45HLsdu

From panel and cohort studies to retrospective research. There can be many occasions when you might be required to carry out repeated observations with longitudinal surveys. Find out more about what it is and it's benefits on our longitudinal surveys page. https://hubs.la/Q02cjJBf0

How do non-Indigenous One Health Researchers trained in Western modalities and academia proactively improve allyship to Indigenous science and scientists? A new collaborative article entitled "One Health, many perspectives: Exploring Indigenous and Western epistemologies" aims to explore this topic. https://lnkd.in/gV4MbhzW

Associate Director, Stuart Mealing, and Principal Statistician, Joe Moss, have co-authored a paper, "Development of a health economic model to evaluate the cost-effectiveness of roxadustat in treating anemia associated with non-dialysis-dependent chronic kidney disease", published in the Journal of Medical Economics | https://lnkd.in/dWShaN5e

🔎 💡 #methods #of #evaluation METHEVAL seminar "Theory-building in global health: how realist evaluation considers the role of context" with Sara Van Belle (Institute of Tropical Medicine, Antwerp) and Bruno Marchal (Institute of Tropical Medicine, Antwerp). 📅 March 14th. 5pm-6pm. 📌 Register here to participate via Zoom: bit.ly/3TlxLO6 With biomedicine as prime influence, randomized controlled trials were considered for a long time at the top of a hierarchical pyramid of evidence in global health. However, another perspective and view on causality has gradually been gaining ground. Increasingly, health is being considered as a complex social phenomenon embedded in a specific system and context. The Covid-19 pandemic, with its intersecting uncertainties at multiple levels, has further exposed the need for a contextual turn in global health. Complexity thinking in health is oriented towards a better understanding of health systems and its embeddedness in a systemic context is currently having a momentum. Realist Evaluation is part of these complexity-oriented methodologies that put context front and centre. We explore how realist evaluation tackles the role of context in its causal analysis. #methods #evaluation #realistevaluation #publicpolicy #seminar #research Sciences Po Sciences Po Research Quadrant Conseil Société Française de l'Evaluation EvalPartners European Evaluation Society (EES) Anne Revillard Thomas Delahais Valérie Pattyn Ana Manzano Antonin Thyrard Douglas Besharov Julia Littell Rebecca A. Maynard Tom Ling 

Glad to see our regional epidemiological study on the Seroprevalence of viral Hepatitis B and C in a target population of pregnant women is still getting attention. Although the study reported a decline in prevalence compared to previous studies in the region, especially in the more urban and literate groups, the implications of health seeking behaviors, access to healthcare services and WASH infrastructure continue to account for differences within and between groups. Studies such as these, help us all as stakeholders to appreciate the importance of preventive and social medicine in the healthcare value chain, especially in the face of competing demand for limited health expenditure. From a researcher’s perspective, we naturally recommend that trends like these ought to inform proactive and wholistic interventions at institutional and household levels. In my current role, where I support our work with multilateral development organizations like the World Bank, it has been very insightful and satisfying to learn of the scale and impact of their various health and social sector projects. How they rely heavily on scientific data such as this, to inform development interventions. Equally validating to witness how a background in applied medical science and research, empowers one to contribute to such large scale and impactful projects, even from a Business Development context. Thank you kindly Dr. Michael Klug for the opportunity to learn from you and contribute, however modest, to this very impactful work with International Financial Institutions. Friends, feel free to peruse our research and share your thoughts. #infectiousdiseases #developmentresearch #multilateraldevelopmentbanks #healthsectorinterventions #accesstocare